| LATEST NEWS | Malaysia must preserve domestic stability, policy certainty and reform momentum amid heightened geopolitical tensions and continued volatility in global markets - PM Anwar | Moody's retains Malaysia’s long-term local and foreign currency issuer ratings at A3, with a stable outlook - MoF | Moody's projects Malaysia's economy to grow faster than all other A-rated peers in 2026 - MoF | PM Anwar urges Melaka DAP to postpone decision to quit state govt administration | Melaka DAP announces withdrawal from state government, resignation from all positions held in BN-led administration | |
KUALA LUMPUR, July 14 (Bernama) -- Glyken Bio Products Sdn Bhd (Glyken) and Japan's Ortho Group have inked a research collaboration worth more than RM4 million to explore the application of Glyken's proprietary bird’s nest extracts in therapeutic medicine and healthcare development.
